Baker Tilly Wealth Management’s Elevance Health ELV Stock Holding History

Baker Tilly Wealth Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,415	Closed	-$629K	–	491
2023 Q2	$629K	Sell	1,415 -327	-19%	-$151K	0.07%	284
2023 Q1	$801K	Buy	1,742 +695	+66%	+$331K	0.09%	240
2022 Q4	$537K	Sell	1,047 -3	-0.3%	-$1.52K	0.07%	303
2022 Q3	$477K	Buy	1,050 +425	+68%	+$203K	0.07%	299
2022 Q2	$302K	Hold	625	–	–	0.04%	411
2022 Q1	$307K	Sell	625 -304	-33%	-$139K	0.03%	425
2021 Q4	$431K	Buy	929 +342	+58%	+$144K	0.05%	381
2021 Q3	$219K	Sell	587 -42	-7%	-$16K	0.03%	473
2021 Q2	$240K	Sell	629 -12	-2%	-$4.59K	0.04%	442
2021 Q1	$230K	Buy	+641	New	+$206K	0.05%	421

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Baker Tilly Wealth Management's ELV Position: Q3 2023 in Review

Baker Tilly Wealth Management sold out of Elevance Health (ELV) in Q3 2023, closing a stake of 1,415 shares — an estimated $629K sold.

Baker Tilly Wealth Management first reported a position in ELV in Q1 2021 and held it in 10 quarters. The position peaked at $801K in Q1 2023. 1,523 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

Baker Tilly Wealth Management reported no remaining Elevance Health position as of Q3 2023 after selling out during the quarter.
Baker Tilly Wealth Management sold 1,415 Elevance Health shares in Q3 2023, an estimated $629K.
Baker Tilly Wealth Management first reported a position in Elevance Health in Q1 2021 and held it in 10 quarters.
Baker Tilly Wealth Management's Elevance Health position peaked at $801K in Q1 2023.
1,523 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on Baker Tilly Wealth Management's 13F filing for Q3 2023, filed 10 Oct 2023.